Tata Chemicals · NSE: TATACHEM · BSE: 500770
Q4 FY26 results · Jan–Mar 2026
Tata Chemicals reported revenue from operations of ₹3,438.00 crore (down 2.0% from Q4 FY25) and net loss of ₹2,116.00 crore for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 3,438.00 | 3,509.00 | −2.0% | 3,550.00 | −3.2% |
| Other income | 44.00 | 42.00 | +4.8% | 38.00 | +15.8% |
| Total income | 3,482.00 | 3,551.00 | −1.9% | 3,588.00 | −3.0% |
| Profit before share of associates & JVs and tax | (2,015.00) | (116.00) | Loss widened | (110.00) | Loss widened |
| Share of profit/(loss) of associates & JVs | 33.00 | 24.00 | 37.00 | ||
| Net profit for the period | (2,116.00) | (49.00) | Loss widened | (69.00) | Loss widened |
| Attributable to shareholders of the company | (2,132.00) | (56.00) | Loss widened | (93.00) | Loss widened |
| EPS, basic (₹) | (83.68) | (2.19) | Loss widened | 3.65 | Turned loss |
| Net margin (%) | -61.5 | -1.4 | -1.9 |
This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,254.00 | 1,219.00 | +2.9% | 1,204.00 | +4.2% |
| Other income | 28.00 | 21.00 | +33.3% | 16.00 | +75.0% |
| Total income | 1,282.00 | 1,240.00 | +3.4% | 1,220.00 | +5.1% |
| Profit before tax | 55.00 | 102.00 | −46.1% | 73.00 | −24.7% |
| Net profit for the period | 48.00 | 115.00 | −58.3% | 73.00 | −34.2% |
| EPS, basic (₹) | 1.88 | 4.51 | −58.3% | 2.87 | −34.5% |
| Net margin (%) | 3.8 | 9.4 | 6.1 |
Consolidated
- Filed with BSE
- 04 May 2026, 20:14 IST
- Board meeting
- 04 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 04 May 2026, 20:14 IST
- Board meeting
- 04 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE